Beta-O2
Beta-O2 is a biotech company developing the ßAir Bio-artificial Pancreas, intended to cure Type 1 diabetes (TID). According to the JDRF, as many as 3 million Americans may have T1D.
back to Directory
Discover the most promising early-stage companies in life sciences, scouted by BioPharmaTrend. Follow company news and important business events.
Beta-O2 is a biotech company developing the ßAir Bio-artificial Pancreas, intended to cure Type 1 diabetes (TID). According to the JDRF, as many as 3 million Americans may have T1D.